Respiratory Syncytial Virus Bronchiolitis Before and After COVID-19 Pandemic: Has the Immunity Debt Been Paid Off?
Journal
The Pediatric infectious disease journal
ISSN: 1532-0987
Titre abrégé: Pediatr Infect Dis J
Pays: United States
ID NLM: 8701858
Informations de publication
Date de publication:
28 Feb 2024
28 Feb 2024
Historique:
medline:
7
3
2024
pubmed:
7
3
2024
entrez:
7
3
2024
Statut:
aheadofprint
Résumé
Our aim was to hypothesize that the COVID-19 pandemic influenced the characteristics of viral bronchiolitis by comparing the last 3 epidemics with 3 pre-COVID-19 epidemics in infants hospitalized with bronchiolitis. We prospectively enrolled 637 consecutive infants (median age 3.0 ± 2.1 months, 58.5% males), hospitalized for bronchiolitis during 6 consecutive annual epidemic seasons from 2017 to 2023. All parents of the children were given a structured anamnestic questionnaire. A nasopharyngeal aspirate was tested for 15 respiratory viruses. As measures of severity, we evaluated the O2 supplementation and the admission at the pediatric intensive care unit. A total of 166 were hospitalized with bronchiolitis in 2017-2018, 97 in 2018-2019, 69 in 2019-2020, 0 in 2020-2021, 129 in 2021-2022 and 176 in 2022-2023. Taking together the 332 bronchiolitis cases hospitalized during the 3 prepandemic seasons, they peaked between December and January; after the flat curve in 2020-2021, the cases of bronchiolitis peaked in November 2021 and in December 2022. While the 2021-2022 season registered a less severe clinical presentation, O2 supplementation and pediatric intensive care unit admissions increased in 2022-2023 with respect to the prepandemic seasons (P < 0.001). This study represents an important scientific demonstration of the impact of primary prevention measures on the epidemiology of viral infections; their fluctuations were related to the intensity of restrictive measures and to the changing trend of respiratory viruses. It is essential to predict the real temporal trend of bronchiolitis in order not to leave high-risk children uncovered and to guide hospitals to maintain a high level of readiness.
Sections du résumé
BACKGROUND
BACKGROUND
Our aim was to hypothesize that the COVID-19 pandemic influenced the characteristics of viral bronchiolitis by comparing the last 3 epidemics with 3 pre-COVID-19 epidemics in infants hospitalized with bronchiolitis.
METHODS
METHODS
We prospectively enrolled 637 consecutive infants (median age 3.0 ± 2.1 months, 58.5% males), hospitalized for bronchiolitis during 6 consecutive annual epidemic seasons from 2017 to 2023. All parents of the children were given a structured anamnestic questionnaire. A nasopharyngeal aspirate was tested for 15 respiratory viruses. As measures of severity, we evaluated the O2 supplementation and the admission at the pediatric intensive care unit.
RESULTS
RESULTS
A total of 166 were hospitalized with bronchiolitis in 2017-2018, 97 in 2018-2019, 69 in 2019-2020, 0 in 2020-2021, 129 in 2021-2022 and 176 in 2022-2023. Taking together the 332 bronchiolitis cases hospitalized during the 3 prepandemic seasons, they peaked between December and January; after the flat curve in 2020-2021, the cases of bronchiolitis peaked in November 2021 and in December 2022. While the 2021-2022 season registered a less severe clinical presentation, O2 supplementation and pediatric intensive care unit admissions increased in 2022-2023 with respect to the prepandemic seasons (P < 0.001).
CONCLUSIONS
CONCLUSIONS
This study represents an important scientific demonstration of the impact of primary prevention measures on the epidemiology of viral infections; their fluctuations were related to the intensity of restrictive measures and to the changing trend of respiratory viruses. It is essential to predict the real temporal trend of bronchiolitis in order not to leave high-risk children uncovered and to guide hospitals to maintain a high level of readiness.
Identifiants
pubmed: 38451927
doi: 10.1097/INF.0000000000004314
pii: 00006454-990000000-00774
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors have no conflicts of interest to disclose.
Références
Obando-Pacheco P, Justicia-Grande AJ, Rivero-Calle I, et al. Respiratory syncytial virus seasonality: a global overview. J Infect Dis. 2018;217:1356–1364.
Cangiano G, Nenna R, Frassanito A, et al. Bronchiolitis: analysis of 10 consecutive epidemic seasons. Pediatr Pulmonol. 2016;51:1330–1335.
Li Y, Wang X, Blau DM, et al.; Respiratory Virus Global Epidemiology Network. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis. Lancet. 2022;399:2047–2064.
Midulla F, Di Mattia G, Nenna R, et al. Novel variants of respiratory syncytial virus A ON1 associated with increased clinical severity of bronchiolitis. J Infect Dis. 2020;222:102–110.
Lazzerini M, Barbi E, Apicella A, et al. Delayed access or provision of care in Italy resulting from fear of COVID-19. Lancet Child Adolesc Health. 2020;4:e10–e11.
Nenna R, Matera L, Licari A, et al.; ICHRIS Group. An Italian multicenter study on the epidemiology of respiratory syncytial virus during SARS-CoV-2 pandemic in hospitalized Children. Front Pediatr. 2022;10:930281.
Yeoh DK, Foley DA, Minney-Smith CA, et al. Impact of Coronavirus Disease 2019 public health measures on detections of influenza and respiratory syncytial virus in children during the 2020 Australian winter. Clin Infect Dis. 2021;72:2199–2202.
Groves HE, Papenburg J, Mehta K, et al.; for members of the Canadian Immunization Monitoring Program Active (IMPACT). The effect of the COVID-19 pandemic on influenza-related hospitalization, intensive care admission and mortality in children in Canada: a population-based study. Lancet Reg Health Am. 2022;7:100132.
Kim JH, Roh YH, Ahn JG, et al. Respiratory syncytial virus and influenza epidemics disappearance in Korea during the 2020-2021 season of COVID-19. Int J Infect Dis. 2021;110:29–35.
Saravanos GL, Hu N, Homaira N, et al. RSV epidemiology in Australia before and during COVID-19. Pediatrics. 2022;149:e2021053537.
Agha R, Avner JR. Delayed seasonal RSV surge observed during the COVID-19 pandemic. Pediatrics. 2021;148:e2021052089.
Stein RT, Zar HJ. RSV through the COVID-19 pandemic: burden, shifting epidemiology, and implications for the future. Pediatr Pulmonol. 2023;58:1631–1639.
Daniels D, Wang D, Suryadevara M, et al. Epidemiology of RSV bronchiolitis among young children in central New York before and after the onset of the COVID-19 pandemic. Pediatr Infect Dis J. 2023;42:1056–1062.
Cohen R, Levy C, Rybak A, et al. Immune debt: recrudescence of disease and confirmation of a contested concept. Infect Dis Now. 2023;53:104638.
Virgili F, Petrarca L, Conti MG, et al. Acute bronchiolitis in Post-COVID era: is the immunity debt paid off?. Clin Case Rep Int. 2023;7:1473.
Scagnolari C, Midulla F, Selvaggi C, et al. Evaluation of viral load in infants hospitalized with bronchiolitis caused by respiratory syncytial virus. Med Microbiol Immunol. 2012;201:311–317.
Van Brusselen D, De Troeyer K, Ter Haar E, et al. Bronchiolitis in COVID-19 times: a nearly absent disease?. Eur J Pediatr. 2021;180:1969–1973.
Jones N. How COVID-19 is changing the cold and flu season. Nature. 2020;588:388–390.
Abbasi J. “This Is Our COVID”-what physicians need to know about the pediatric RSV surge. JAMA. 2022;328:2096–2098.
Rao S, Armistead I, Messacar K, et al. Shifting epidemiology and severity of respiratory syncytial virus in children during the COVID-19 pandemic. JAMA Pediatr. 2023;177:730–732.
Wang L, Davis PB, Berger NA, et al. Disrupted seasonality and association of COVID-19 with medically attended respiratory syncytial virus infections among young children in the US: January 2010-January 2023. medRxiv. 2023.
Nenna R, Stern DA, Carr TF, et al. Prenatal exposure to RSV season influences first-year risk of RSV lower respiratory illness and RSV-specific immune responses assessed at birth. J Virol. 2023;97:e0076723.
Pierangeli A, Nenna R, Fracella M, et al. Genetic diversity and its impact on disease severity in respiratory syncytial virus subtype-A and -B bronchiolitis before and after pandemic restrictions in Rome. J Infect. 2023;87:305–314.
Midulla F, Nenna R, Scagnolari C, et al. How respiratory syncytial virus genotypes influence the clinical course in infants hospitalized for bronchiolitis. J Infect Dis. 2019;219:526–534.
Englund J, Glezen WP, Piedra PA. Maternal immunization against viral disease. Vaccine. 1998;16:1456–1463.
Zven S, Dorr M, Malloy AMW, et al. Predicting the RSV surge: pediatric RSV patterns of the COVID pandemic. Pediatr Infect Dis J. 2023;42:e349–e351.